These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 871632)
1. Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Inman WH Br Med J; 1977 Jun; 1(6075):1500-5. PubMed ID: 871632 [TBL] [Abstract][Full Text] [Related]
2. Phenylbutazone, oxyphenbutazone labeling revised. FDA Drug Bull; 1984 Dec; 14(3):23-4. PubMed ID: 6526172 [No Abstract] [Full Text] [Related]
3. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part I. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(2):97-136. PubMed ID: 3529881 [No Abstract] [Full Text] [Related]
4. Aplastic anaemia. II. Drug-induced aplastic anaemia. Böttiger LE; Westerholm B Acta Med Scand; 1972 Oct; 192(4):319-21. PubMed ID: 5081069 [No Abstract] [Full Text] [Related]
5. Phenylbutazone, oxyphenbutazone and aplastic anaemia. Böttiger LE Br Med J; 1977 Jul; 2(6081):265. PubMed ID: 884472 [No Abstract] [Full Text] [Related]
6. Phenylbutazone and oxyphenbutazone: time to call a halt. Drug Ther Bull; 1984 Jan; 22(2):5-6. PubMed ID: 6692755 [No Abstract] [Full Text] [Related]
7. Aplastic anaemia. I. Incidence and aetiology. Böttiger LE; Westerholm B Acta Med Scand; 1972 Oct; 192(4):315-8. PubMed ID: 5081068 [No Abstract] [Full Text] [Related]
8. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087 [TBL] [Abstract][Full Text] [Related]
9. [Agranulocytosis caused by medication]. Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1248-9. PubMed ID: 4105253 [No Abstract] [Full Text] [Related]
10. Drug-induced blood dyscrasias in Sweden. Böttiger LE; Westerholm B Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II. Chaplin S Adverse Drug React Acute Poisoning Rev; 1986; 5(3):181-96. PubMed ID: 3538824 [No Abstract] [Full Text] [Related]
12. The sensitivity of human bone marrow granulocyte/monocyte precursor cells to phenylbutazone, oxyphenbutazone and gamma-hydroxyphenylbutazone in vitro, with observations on the bone marrow colony formation in phenylbutazone-induced granulocytopoenia. Smith CS; Chinn S; Watts RW Biochem Pharmacol; 1977 May; 26(9):847-52. PubMed ID: 861050 [No Abstract] [Full Text] [Related]
17. [Current aspects of iatrogenic lesions of the bone marrow]. Hausmann K; Skrandies G; Sachtleben P Minerva Med; 1976 Nov; 67(55):3583-90. PubMed ID: 995304 [TBL] [Abstract][Full Text] [Related]
18. Adverse reactions with long-term use of phenylbutazone and oxyphenbutazone. Sperling IL Lancet; 1969 Sep; 2(7619):535-7. PubMed ID: 4184850 [No Abstract] [Full Text] [Related]
19. [Present aspects of bone marrow lesions due to drugs (author's transl)]. Hausmann K; Skrandies G; Sachtleben P MMW Munch Med Wochenschr; 1974 Sep; 116(38):1621-6. PubMed ID: 4215965 [No Abstract] [Full Text] [Related]